Loading...

PR Information Data

130 개 2 페이지
번호 컨텐츠
115 Global COVID-19 Overcoming Collaboration Group ‘IVRA’ Launched, “Proposed Treatment Guide” 2024-03-12   35 (주)아디포랩스
114 'REMISSION 1℃’ to fight COVID-19 is exported worldwide 2024-03-12   37 (주)아디포랩스
113 “COVID-19 treatment needs a major shift to hyperthermia therapy.” 2024-03-12   37 (주)아디포랩스
112 AdipoLABs CEO Han Sung-ho visits the National Cemetery 2024-03-12   37 (주)아디포랩스
111 A new horizon in cancer treatment, the world is paying attention to hyperthermia cancer treatment device of ‘REMISSON 1℃’ 2024-03-29   37 (주)아디포랩스
110 Presentng a new direction for COVID-19 and cancer treatment 2024-03-12   38 (주)아디포랩스
109 AdipoLABs launches ‘high-frequency hyperthermia cancer treatment device’ in Malaysia 2024-03-29   38 (주)아디포랩스
108 “Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃” 2024-03-12   40 (주)아디포랩스
107 AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia 2024-03-28   40 (주)아디포랩스
106 AdipoLABs seeks to have an academic collaboration for cancer treatment with University of Cyberjaya, Malaysia 2024-03-28   41 (주)아디포랩스
105 AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia 2024-03-28   41 (주)아디포랩스
104 World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched. 2024-03-12   44 (주)아디포랩스
103 “COVID-19 treatment needs a major shift to hyperthermia therapy.” 2024-03-12   45 (주)아디포랩스
102 AdipoLABs, ‘leading the way’ in practicing love for humanity around the world 2024-03-14   45 (주)아디포랩스
101 AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council. 2024-03-14   45 (주)아디포랩스